Sign in
Taking peopleNo phase

Valve Calcium and Long-Term Health After Valve Replacement for Aortic Stenosis

Studies valve calcium in people having valve replacement for aortic stenosis.

Key facts

Who runs it
Eunpyeong St. Mary's Hospital
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: SAINT-TAVR Calcium Registry
Status
Recruiting
People taking part
500 people, planned
Started
2 Oct 2024
Expected to end
2 Oct 2034
Type of study
Observational
Treatments tested
  • Transcatheter aortic valve replacement with ballon-expandable or self-expandable valves
Record updated
9 December 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have had TAVR (a heart valve replaced through a tube in a blood vessel) for severe aortic stenosis. It studies how calcium in the valve ring affects health over 3 years.

Age
19 years or older
Sex
All
Disease stage
Severe aortic stenosis (narrowing of the main heart valve)
Earlier treatment
Must have had transcatheter aortic valve replacement (TAVR) as part of regular care.

Main reasons for not taking part

  • People who have not given written informed consent for this study cannot join.

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Adults aged 19 years or older
  • Patients who have undergone transcatheter aortic valve replacement (TAVR) for severe aortic stenosis
  • Individuals who have voluntarily provided written informed consent to participate

Who cannot take part

  • Individuals who have not provided written informed consent for this study

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to learn about the long-term effects of aortic valve annular calcification in patients undergoing transcatheter aortic valve replacement (TAVR). The main question it aims to answer is:

Read full original descriptionShow less

Does the degree of aortic valve annular calcification prior to TAVR influence long-term clinical outcomes, including major adverse cardiovascular events including all-cause mortality, over a 3-year period?

Participants who have undergone TAVR as part of their regular medical care for severe aortic stenosis will have their pre-procedural imaging and clinical outcomes evaluated for a 3-year follow-up period.

Treatments tested

  • Transcatheter aortic valve replacement with ballon-expandable or self-expandable valves

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: Scientific Association of Interventional Cardiology - Transcatheter Aortic Valve Replacement (SAINT-TAVR) Calcium Registry
Plain-language title
Valve Calcium and Long-Term Health After Valve Replacement for Aortic StenosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
9 December 2024